News & Updates

Show Multimedia Only

Impaired kidney function influences AD blood biomarkers but not dementia risk

17 Dec 2025 by

Among individuals without cognitive impairment, those with impaired kidney function exhibit increased levels of Alzheimer’s disease (AD) blood biomarkers, although they do not appear to be at increased risk of dementia compared with those who have preserved kidney function, according to new research.

Impaired kidney function influences AD blood biomarkers but not dementia risk

17 Dec 2025

Atopic dermatitis may inhibit growth in children, but dupilumab helps

17 Dec 2025

Children with atopic dermatitis (AD) are at greater risk of impaired linear growth, but treatment with dupilumab may lessen the risk, suggests a study.

Atopic dermatitis may inhibit growth in children, but dupilumab helps

17 Dec 2025

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

17 Dec 2025

Outcomes are similar among patients with moderate-to-severe psoriasis who continued treatment with ustekinumab and those who switched to BAT2206, a drug being developed as a biosimilar of ustekinumab, according to a study.

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

17 Dec 2025

EPVS burden a potential marker of CSVD, AD-related pathology

17 Dec 2025 by

A study from Singapore reports the potential of enlarged perivascular space (EPVS) burden as a marker of cerebral small vessel disease (CSVD) and Alzheimer’s disease (AD)-related blood-based biomarker (BBM) pathology.

EPVS burden a potential marker of CSVD, AD-related pathology

17 Dec 2025

Vitamin D status in pregnancy implicated in early childhood dental caries

17 Dec 2025

Higher maternal 25-hydroxyvitamin D (25[OH]D) levels throughout pregnancy appear to reduce the likelihood of dental caries in offspring in early childhood, according to a prospective study from China.

Vitamin D status in pregnancy implicated in early childhood dental caries

17 Dec 2025

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

17 Dec 2025 by

Treatment with iGlarLixi* resulted in better clinical outcomes than IDegAsp** in Chinese adults with type 2 diabetes (T2D), regardless of age or disease duration at baseline, according to a post hoc analysis of the phase III Soli-D study presented at ATTD-ASIA 2025.

Insulin glargine plus lixisenatide improves outcomes in Chinese adults with T2D

17 Dec 2025

Abnormalities in kidney, ureter, bladder tied to UTI recurrence, renal scarring in infants

16 Dec 2025 by

In infants who had a first urinary tract infection (UTI), the risks of recurrence and renal scarring appear to be high in the presence of kidney, ureter, and bladder abnormalities on ultrasound, according to a retrospective study from Singapore.